Skip to content

HELIX BIOMEDIX INC: 10-Q filed 2012-11-08

What HELIX BIOMEDIX INC reported in its quarterly report filed 2012-11-08 (fiscal Q3 2012): 38 published measures, 109 facts as tagged in accession 0001437749-12-011259.

This filing

Form
10-Q (quarterly report)
Filed
2012-11-08
Fiscal period
fiscal Q3 2012
Accession
0001437749-12-011259 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All HELIX BIOMEDIX INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-09-301,701,922USD
At 2011-12-312,974,639USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-09-30551,928USD
At 2011-12-31439,303USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-09-301,149,994USD
At 2011-12-312,535,336USD
At 2010-12-314,874,444USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-09-30216,534USD
At 2011-12-311,688,945USD
At 2011-09-302,067,262USD
At 2010-12-314,044,309USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-785,184USD92
2012-01-01 to 2012-09-30-2,035,321USD274
2011-01-01 to 2011-12-31-2,488,576USD365
2011-07-01 to 2011-09-30-605,617USD92
2011-01-01 to 2011-09-30-1,940,226USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-1,434,680USD274
2011-01-01 to 2011-09-30-1,911,723USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-09-3010,731USD274
2011-01-01 to 2011-09-302,669USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-07-01 to 2012-09-30469,071USD92
2012-01-01 to 2012-09-301,620,015USD274
2011-07-01 to 2011-09-30394,707USD92
2011-01-01 to 2011-09-301,445,438USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-37,731USD274
2011-01-01 to 2011-09-30-65,324USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-09-30-48,092,159USD
At 2011-12-31-46,056,838USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-07-01 to 2012-09-3049,720,255shares92
2012-01-01 to 2012-09-3049,720,255shares274
2011-07-01 to 2011-09-3049,720,255shares92
2011-01-01 to 2011-09-3049,720,255shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-0.02USD/shares92
2012-01-01 to 2012-09-30-0.04USD/shares274
2011-07-01 to 2011-09-30-0.01USD/shares92
2011-01-01 to 2011-09-30-0.04USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-09-3019,602USD
At 2011-12-3126,098USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-07-01 to 2012-09-3033,171USD92
2012-01-01 to 2012-09-30185,109USD274
2011-01-01 to 2011-12-31149,468USD365
2011-07-01 to 2011-09-3014,015USD92
2011-01-01 to 2011-09-30132,964USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-748,173USD92
2012-01-01 to 2012-09-30-1,878,387USD274
2011-07-01 to 2011-09-30-591,091USD92
2011-01-01 to 2011-09-30-1,859,323USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-09-301,210,072USD
At 2011-12-312,558,105USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-09-30519,670USD
At 2011-12-31410,643USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-09-30321,565USD
At 2011-12-31125,324USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2012-09-3095,470USD
At 2011-12-31146,297USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-09-30284,809USD
At 2011-12-31239,773USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-07-01 to 2012-09-301,082,005USD92
2012-01-01 to 2012-09-302,989,175USD274
2011-07-01 to 2011-09-30858,003USD92
2011-01-01 to 2011-09-302,703,446USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-09-30330,989USD
At 2011-12-31363,869USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-07-01 to 2012-09-30333,832USD92
2012-01-01 to 2012-09-301,110,788USD274
2011-07-01 to 2011-09-30266,912USD92
2011-01-01 to 2011-09-30844,123USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2012-07-01 to 2012-09-30135,239USD92
2012-01-01 to 2012-09-30509,227USD274
2011-07-01 to 2011-09-30127,795USD92
2011-01-01 to 2011-09-30601,315USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-07-01 to 2012-09-30133,009USD92
2012-01-01 to 2012-09-30308,036USD274
2011-07-01 to 2011-09-30109,221USD92
2011-01-01 to 2011-09-30425,131USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-09-3049,720,255shares
At 2011-12-3149,720,255shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-09-3049,192,432USD
At 2011-12-3148,542,453USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-09-30641,040USD
At 2011-12-31678,559USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-09-30621,438USD
At 2011-12-31652,461USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-09-308,522USD
At 2011-12-3120,884USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-09-3063,603USD
At 2011-12-3155,463USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-30418,868USD92
2012-01-01 to 2012-09-301,132,679USD274
2011-07-01 to 2011-09-30327,162USD92
2011-01-01 to 2011-09-301,043,843USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-07-01 to 2012-09-305,954USD92
2012-01-01 to 2012-09-3017,227USD274
2011-07-01 to 2011-09-3010,902USD92
2011-01-01 to 2011-09-3031,781USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2012-07-01 to 2012-09-3016,942USD92
2012-01-01 to 2012-09-3050,827USD274
2011-07-01 to 2011-09-3016,943USD92
2011-01-01 to 2011-09-3050,828USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-37,011USD92
2012-01-01 to 2012-09-30-156,934USD274
2011-07-01 to 2011-09-30-14,526USD92
2011-01-01 to 2011-09-30-80,903USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-3045,036USD274
2011-01-01 to 2011-09-3019,097USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-32,880USD274
2011-01-01 to 2011-09-3077,695USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-30196,241USD274
2011-01-01 to 2011-09-30-54,547USD273

Inspect the source

Entity
HELIX BIOMEDIX INC / CIK 0000831749
Captured
SEC response SHA-256
5e05a3f74aa61c25667dbbea76c6d7318ee5bd5ce089342ac35e249776b3e1b5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000831749.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))